- Home
- NERV vs BHAT Comparison
NERV vs BHAT Comparison
Compare NERV & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- BHAT
- Stock Information
- Founded
- NERV 2007
- BHAT 2010
- Country
- NERV United States
- BHAT China
- Employees
- NERV N/A
- BHAT N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- BHAT Recreational Games/Products/Toys
- Sector
- NERV Health Care
- BHAT Consumer Discretionary
- Exchange
- NERV Nasdaq
- BHAT Nasdaq
- Market Cap
- NERV 12.6M
- BHAT 10.3M
- IPO Year
- NERV 2014
- BHAT 2019
- Fundamental
- Price
- NERV $1.73
- BHAT $1.75
- Analyst Decision
- NERV Hold
- BHAT
- Analyst Count
- NERV 1
- BHAT 0
- Target Price
- NERV $5.00
- BHAT N/A
- AVG Volume (30 Days)
- NERV 12.1K
- BHAT 473.5K
- Earning Date
- NERV 08-05-2025
- BHAT 04-30-2025
- Dividend Yield
- NERV N/A
- BHAT N/A
- EPS Growth
- NERV N/A
- BHAT N/A
- EPS
- NERV 0.83
- BHAT N/A
- Revenue
- NERV N/A
- BHAT $18,724,190.00
- Revenue This Year
- NERV N/A
- BHAT N/A
- Revenue Next Year
- NERV N/A
- BHAT N/A
- P/E Ratio
- NERV $2.06
- BHAT N/A
- Revenue Growth
- NERV N/A
- BHAT N/A
- 52 Week Low
- NERV $1.15
- BHAT $1.62
- 52 Week High
- NERV $3.50
- BHAT $145.00
- Technical
- Relative Strength Index (RSI)
- NERV 50.22
- BHAT 43.49
- Support Level
- NERV $1.57
- BHAT $1.61
- Resistance Level
- NERV $1.88
- BHAT $2.12
- Average True Range (ATR)
- NERV 0.09
- BHAT 0.11
- MACD
- NERV -0.02
- BHAT -0.01
- Stochastic Oscillator
- NERV 52.03
- BHAT 27.82
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.